JAAD Case Reports (Aug 2023)

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa–associated refractory pruritus

  • Lauren C. LaMonica, MPH,
  • Margaret Lang-Houser, MD,
  • Scott C. Bresler, MD, PhD,
  • Julie E. Mervak, MD

Journal volume & issue
Vol. 38
pp. 82 – 85

Abstract

Read online

No abstracts available.

Keywords